Skip to main content
Clinical Trials/ChiCTR-CCC-12002526
ChiCTR-CCC-12002526CompletedNot Applicable

皮质抑素在寻常型银屑病患者皮肤低表达以及其抑制角质形成细胞增殖活性研究

中国博士后基金1 site in 1 country220 target enrollmentStarted: September 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
220
Locations
1
Primary Endpoint
血浆中皮质抑素的浓度

Study Overview

Brief Summary

探究神经递质皮质抑素(CST)在寻常型银屑病患者的表达变化以及其对角质形成细胞株增殖的抑制作用,从而获得证据论证 CST 是银屑病可能的发病因素

Study Design

Study Type
病因学/相关因素研究
Primary Purpose
病例对照研究

Eligibility Criteria

Ages
15 to 62 (—)
Sex
All

Inclusion Criteria

  • 寻常型银屑病患者经临床医生诊断并结合病理学检查确诊仅患有银屑病的患者;经体检身体各项指标均正常的健康志愿者。

Exclusion Criteria

  • 寻常型银屑病患者伴随其他疾病;对照组出现任何体检指标不合格;患者自述有身体其他部位不适

Arms & Interventions

对照组

银屑病组

Outcomes

Primary Outcomes

血浆中皮质抑素的浓度

皮肤中皮质抑素表达量

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
中国博士后基金

Study Sites (1)

Loading locations...

Similar Trials